Any reference to biological activity or potential effects is based solely on preclinical or invitro findings and should not be interpreted as validated clinical outcomes
Purpose-built for physicians Benefits of GLP-1s outweigh harms when patients achieve 10% weight loss Key takeaways: Although achieving 10% weight loss outweighed the harms of GLP-1 receptor agonists, 5% weight loss did not
Both treatments can offer significant weight loss results, but Dr
FDA approves first treatment for patients with liver scarring due to fatty liver disease
Avoid repeated freeze-thaw cycles, as thermal stress can cause peptide degradation and loss of biological activity
Janet Tomiyama, PhD, a health psychologist at the University of California, Los Angeles, wrote in a 2025 commentary, (GLP-1s) have the potential to increase weight stigma, medicalize larger bodies, and shame people for both taking the perceived easy way outor not taking it